Stentys announced the first distribution agreements for its drug-eluting stent for treating below-the-knee (BTK) arteries in Germany and Belgium, making it the first self-expanding drug-eluting stent commercialized for this indication in Europe.

CardioAlex

Celebrating CardioAlex’s 15th anniversary, this is the most comprehensive and biggest cardiology event in the middle East and Africa .The theme of this conference is "Connecting Cardiologists”. It will be held at Bibliotheca Alexandrina, Alexandria – Egypt from May 31 to June 3, 2016. There is an expected attendance of 5,000 delegates and 700 faculty guests.

The widespread belief that radiation from X rays, CT scans and other medical imaging can cause cancer is based on an unproven, decades-old theoretical model, according to a study published in the American Journal of Clinical Oncology.

Contrary to current clinical belief, regular caffeine consumption does not lead to extra heartbeats, which, while common, can lead in rare cases to heart- or stroke-related morbidity and mortality, according to UC San Francisco (UCSF) researchers.

Early diagnosis and treatment of sleep apnea may reduce six-month readmissions for patients hospitalized with heart failure, according to research recently published online by the American Journal of Cardiology.

Intravascular Coronary Imaging and Physiology

Intravascular Coronary Imaging and Physiology is a one-and-a-half-day program providing both detailed and broad examinations of basic and advanced clinical techniques, a review of relevant trial data, and discussion on recent developments in device concepts. Multiple didactic sessions with opportunities for Q&A will be intertwined with several live cases from St. Francis Hospital.

February 4, 2016 — Stereotaxis and Philips have signed an addendum pursuant to their existing Development and Cooperation Agreement to facilitate development of a new interface between each company’s most advanced systems for electrophysiology (EP) and interventional cardiology procedures.

New research from scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) published in the journal Circulation, may lead to a new approach to help treat heart failure early in the disease.

Biotronik announced CE approval for its new Ilivia implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds), improving magnetic resonance imaging (MRI) access for cardiac device patients. Ilivia devices come with the company’s ProMRI technology, as well as MRI AutoDetect.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now